Results 201 to 210 of about 41,715 (245)

Multi-omics dissection of MAPK-driven senescence unveils therapeutic vulnerabilities in KIAA1549::BRAF-fusion pediatric low-grade glioma models. [PDF]

open access: yesSignal Transduct Target Ther
Sigaud R   +12 more
europepmc   +1 more source

Fast pH‐Driven Solubilization Method of Realgar (As4S4) to Reduce the Toxicity of Arsenic [As(III)] for Medicinal Purposes

open access: yesAdvanced Science, EarlyView.
Arsenic trioxide transformed acute promyelocytic leukemia therapy and shows promise against HIV. A new method to solubilize the mineral realgar produces different arsenic species depleting the main arsenic target, nuclear PML protein, and retaining effects on leukemic and HIV reservoir cells, while minimizing off‐target damage.
Bojana Lucic   +20 more
wiley   +1 more source

PD-L1 expression assessment in Angiosarcoma improves with artificial intelligence support. [PDF]

open access: yesJ Pathol Inform
Reith FH   +16 more
europepmc   +1 more source

Single‐Cell RNA Sequencing Identifies MMP11+ Cancer‐Associated Fibroblasts as Drivers of Angiogenesis and Bladder Cancer Progression

open access: yesAdvanced Science, EarlyView.
Single‐cell RNA sequencing identifies MMP11⁺ CAFs as pro‐angiogenic cells accumulating during bladder cancer progression. These cells promote angiogenesis by regulating ESM1⁺ tip endothelial cells and recruiting SPP1⁺ macrophages. Tumor‐derived BMP2 promotes their activation.
Wuwu Xu   +13 more
wiley   +1 more source

Fragment Autoantigens Stimulated T‐Cell‐Immunotherapy (FAST) as a Fast Autologous Cancer Vaccine

open access: yesAdvanced Science, EarlyView.
A personalized whole tumor cell vaccine (FAST) is developed to address immunosuppressive tumor microenvironments and genomic instability‐driven heterogeneity. Irradiation and cryoablation‐treated tumor cells generate fragmented antigens (FAs) that activate broad‐spectrum antigen presentation via upregulated immunogenic cell death, MHC‐I, and damage ...
Yuan Li   +14 more
wiley   +1 more source

Tumour spectrum in <i>AKT1</i>-related Proteus syndrome: a systematic review of clinical reports and series. [PDF]

open access: yesJ Med Genet
Rostagni OM   +7 more
europepmc   +1 more source

Treatment of Central Neurocytoma. [PDF]

open access: yesCancers (Basel)
Michel A   +13 more
europepmc   +1 more source

The plasma miRNAome in ADNI: Signatures to aid the detection of at-risk individuals. [PDF]

open access: yesAlzheimers Dement
Krüger DM   +24 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy